NUS · Insider Trading
NuSkin Enterprises, Inc.
Every open-market purchase and sale reported by NUS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-10 | EDWINA D WOODBURY | Director | A | — | — |
| 2026-06-11 | EDWINA D WOODBURY | Director | A | — | — |
| 2026-06-03 | Pisano R. Thomas | Director | A | — | — |
| 2026-06-03 | Emma S. Battle | Director | A | — | — |
| 2026-06-03 | Mark A Zorko | Director | A | — | — |
| 2026-06-03 | Laura Nathanson | Director | A | — | — |
| 2026-06-03 | James M Winett | Director | MIXED | — | — |
| 2026-06-03 | EDWINA D WOODBURY | Director | MIXED | — | — |
| 2026-06-03 | DANIEL W CAMPBELL | Director | A | — | — |
| 2026-05-12 | Laura Nathanson | Director | Sell | — | — |
| 2026-03-12 | EDWINA D WOODBURY | Director | A | — | — |
| 2026-03-09 | Justin S Keisel | EVP, President of Global Sales | A | — | — |
| 2026-03-09 | Steven Keith Hatchett | Chief Product Officer | A | — | — |
| 2026-03-09 | RYAN S NAPIERSKI | President and CEO | A | — | — |
| 2026-03-09 | James D Thomas | Chief Financial Officer | A | — | — |
| 2026-03-09 | Chayce David Clark | EVP, COO and CLO | A | — | — |
| 2026-03-02 | RYAN S NAPIERSKI | President and CEO | F | — | — |
| 2026-03-02 | James D Thomas | Chief Financial Officer | F | — | — |
| 2026-03-02 | Chayce David Clark | EVP and General Counsel | F | — | — |
| 2026-03-02 | Steven Keith Hatchett | Chief Product Officer | F | — | — |
| 2026-03-02 | Justin S Keisel | EVP, President of Global Sales | F | — | — |
| 2026-02-18 | RYAN S NAPIERSKI | President and CEO | F | — | — |
| 2026-02-18 | Justin S Keisel | EVP, President of Global Sales | F | — | — |
| 2026-02-18 | Chayce David Clark | EVP and General Counsel | F | — | — |
| 2026-02-18 | Steven Keith Hatchett | Chief Product Officer | F | — | — |
| 2026-02-18 | James D Thomas | Chief Financial Officer | F | — | — |
| 2026-02-12 | Justin S Keisel | EVP, President of Global Sales | A | — | — |
| 2026-02-12 | Steven Keith Hatchett | Chief Product Officer | A | — | — |
| 2026-02-12 | RYAN S NAPIERSKI | President and CEO | A | — | — |
| 2026-02-12 | Chayce David Clark | EVP and General Counsel | A | — | — |
| 2026-02-12 | James D Thomas | Chief Financial Officer | A | — | — |
| 2025-12-23 | Chayce David Clark | EVP and General Counsel | F | — | — |
| 2025-12-11 | EDWINA D WOODBURY | Director | A | — | — |
| 2025-11-12 | Steven Keith Hatchett | Chief Product Officer | Buy | — | — |
| 2025-09-11 | EDWINA D WOODBURY | Director | A | — | — |
| 2025-09-04 | Chayce David Clark | EVP and General Counsel | Sell | — | — |
| 2025-09-04 | Laura Nathanson | Director | Sell | — | — |
| 2025-08-29 | DANIEL W CAMPBELL | Director | Sell | — | — |
| 2025-08-05 | Chayce David Clark | EVP and General Counsel | F | — | — |
| 2025-08-05 | James D Thomas | Chief Financial Officer | F | — | — |
| 2025-06-12 | EDWINA D WOODBURY | Director | A | — | — |
| 2025-06-03 | Mark A Zorko | Director | A | — | — |
| 2025-06-03 | Emma S. Battle | Director | MIXED | — | — |
| 2025-06-03 | James M Winett | Director | A | — | — |
| 2025-06-03 | Laura Nathanson | Director | A | — | — |
| 2025-06-03 | EDWINA D WOODBURY | Director | MIXED | — | — |
| 2025-06-03 | Pisano R. Thomas | Director | A | — | — |
| 2025-06-03 | DANIEL W CAMPBELL | Director | A | — | — |
| 2025-05-28 | Steven Keith Hatchett | Chief Product Officer | Buy | — | — |
| 2025-03-24 | Justin S Keisel | EVP, President of Global Sales | L | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chairman of the Board | 3,280,818 | — |
| — | Senior Vice President | 2,660,845 | — |
| — | President and CEO | 1,001,905 | — |
| — | President & CEO | 575,559 | — |
| — | EVP, COO and CLO | 390,746 | — |
| — | Chief Financial Officer | 267,102 | — |
| — | Chief Product Officer | 260,818 | — |
| — | 10%+ Owner | 246,081 | — |
| — | Chief Executive Officer | 175,239 | — |
| — | EVP, President of Global Sales | 160,170 | — |
| — | Director | 116,827 | — |
| — | Chief Scientific Officer | 99,302 | — |
| — | Director | 75,869 | — |
| — | Pres Global Sales & Operations | 65,611 | — |
| — | Director | 62,474 | — |
| — | Director | 60,586 | — |
| — | Director | 57,648 | — |
| — | Chief Financial Officer | 57,146 | — |
| — | Director | 57,116 | — |
| — | 10%+ Owner | 56,819 | — |
| — | General Counsel | 47,359 | — |
| — | Chief Global Growth Officer | 43,204 | — |
| — | Director | 37,448 | — |
| — | President, Americas Region | 34,585 | — |
| — | Director | 34,045 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the NUS quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.